-
Taxonomy & unit
-
ifrs-full: CAD
-
Summary
-
ImmunoPrecise Antibodies Ltd. quarterly/annual Research And Development Expense history and growth rate from Q3 2022 to Q3 2024.
- ImmunoPrecise Antibodies Ltd. Research And Development Expense for the quarter ending October 31, 2024 was CA$1.16M, a 38.3% increase year-over-year.
- ImmunoPrecise Antibodies Ltd. Research And Development Expense for the twelve months ending October 31, 2024 was CA$5.06M.
- ImmunoPrecise Antibodies Ltd. annual Research And Development Expense for 2023 was CA$4.04M, a 71.3% decline from 2022.
- ImmunoPrecise Antibodies Ltd. annual Research And Development Expense for 2022 was CA$14.1M, a 84% increase from 2021.
- ImmunoPrecise Antibodies Ltd. annual Research And Development Expense for 2021 was CA$7.66M, a 288% increase from 2020.
Research And Development Expense, Trailing 12 Months (CAD)
Research And Development Expense, Quarterly (CAD)
Research And Development Expense, YoY Quarterly Growth (%)